Angiotensin-converting enzyme inhibition and prostaglandins
Authors:
- Gordon H. WilliamsGWGordon H. Williams
- 1 April 1982
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (6) , 1405-1409
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.Hypertension, 1981
- Endocrine profile in the long-term phase of converting-enzyme inhibitionClinical Pharmacology & Therapeutics, 1980
- Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatmentEuropean Journal of Pharmacology, 1980
- Plasma concentration and the depressor response to bradykinin infusionLife Sciences, 1980
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pigEuropean Journal of Pharmacology, 1979
- The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.Hypertension, 1979
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Reciprocal Influence of Salt Intake on Adrenal Glomerulosa and Renal Vascular Responses to Angiotensin II in Normal ManJournal of Clinical Investigation, 1974